Diabetic Macular Edema Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
AMPE | F | Ampio Pharmaceuticals, Inc. | 31.47 | |
OCUP | F | Ocuphire Pharma, Inc. | 3.47 | |
ALIM | F | Alimera Sciences, Inc. | -5.98 | |
EPRX | D | Eupraxia Pharmaceuticals Inc. | -2.19 | |
OPT | D | Opthea Limited | -1.65 | |
EYPT | C | EyePoint Pharmaceuticals, Inc. | 2.50 | |
KALV | B | KalVista Pharmaceuticals, Inc. | 7.31 | |
RZLT | B | Rezolute, Inc. | 2.99 | |
OCS | A | Oculis Holding AG | -1.68 |
Related Industries: Biotechnology Drug Manufacturers - Major Shell Companies
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
XPH | D | SPDR S&P Pharmaceuticals ETF | 2.06 | |
PBE | C | PowerShares Dynamic Biotech & Genome | 1.81 | |
PILL | D | Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF | 1.61 | |
BTEC | C | Principal Healthcare Innovators Index ETF | 0.34 | |
IWC | C | iShares Microcap ETF | 0.29 |
Compare ETFs
- Diabetic Macular Edema
Diabetic retinopathy, also known as diabetic eye disease, is a medical condition in which damage occurs to the retina due to diabetes mellitus. It is a leading cause of blindness.Diabetic retinopathy affects up to 80 percent of those who have had diabetes for 20 years or more. At least 90% of new cases could be reduced with proper treatment and monitoring of the eyes. The longer a person has diabetes, the higher his or her chances of developing diabetic retinopathy. Each year in the United States, diabetic retinopathy accounts for 12% of all new cases of blindness. It is also the leading cause of blindness in people aged 20 to 64.
Popular Now
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles